Current standards for first-line therapy of multiple myeloma.
about
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalitiesCharacteristics of bortezomib- and thalidomide-induced peripheral neuropathy.Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols.
P2860
Current standards for first-line therapy of multiple myeloma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Current standards for first-line therapy of multiple myeloma.
@en
type
label
Current standards for first-line therapy of multiple myeloma.
@en
prefLabel
Current standards for first-line therapy of multiple myeloma.
@en
P1476
Current standards for first-line therapy of multiple myeloma.
@en
P2093
Sundar Jagannath
P304
P478
P577
2007-08-01T00:00:00Z